real-time news and commentary for investors
Tuesday, Sep 17
Novartis eyecare unit probes China bribery claims
- Novartis' (NVS) eyecare unit Alcon is investigating accusations that its Chinese staff bribed doctors at over 200 hospitals in order to boost sales.
- Employees are reported to have diverted money that had been allocated for Alcon's post-marketing clinical studies on its lens implants.
- The allegations add to accusations last month that Novartis asked a worker to bribe doctors in order to help boost sales of a cancer drug.
- Danone's (DANOY.PK) baby formula unit Dumex is probing similar corruption claims.